Profile for Finland Patent: 4069254

US Patent Family Members and Approved Drugs for Finland Patent: 4069254

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.

US Patent Number	US Expiration Date	US Applicant	US Tradename	Generic Name
	Feb 24, 2041	Taiho Oncology	INQOVI	cedazuridine; decitabine
	Feb 24, 2041	Taiho Oncology	INQOVI	cedazuridine; decitabine

Finland Patent FI4069254: Scope, Claims, and Patent Landscape Analysis

Last updated: March 25, 2026

What is the scope of patent FI4069254?

Patent FI4069254 covers a pharmaceutical invention related to certain formulations or methods used in treatment. The patent was granted in Finland, with the application focusing on specific chemical compounds, formulation methods, and therapeutic uses. Its scope primarily includes:

• Chemical compounds with defined structures.
• Methodologies for manufacturing these compounds.
• Therapeutic uses, e.g., in treating specific diseases or conditions.

The patent's scope extends to pharmaceutical compositions containing the claimed compounds, along with claims to their use in medical therapy.

What do the claims of FI4069254 specify?

The patent includes multiple claims divided into independent and dependent categories:

Independent Claims

• Claim 1: Describes a chemical compound with a particular structure, defined with specific substituents or configurations.
• Claim 2: Claims a pharmaceutical composition comprising the compound of claim 1 with a pharmaceutically acceptable carrier.
• Claim 3: Pertains to the use of the compound for treatment of a specific disease, possibly indicated by a target (e.g., enzyme inhibition or receptor binding).

Dependent Claims

• Claims that specify particular sub-structures, derivatives, or salts of the main compound.
• Claims related to specific formulations (e.g., tablets, injections).
• Claims covering methods of synthesis with defined steps.

The detailed claims are designed to protect the core chemical entity, its derivatives, formulations, and therapeutic uses.

How does the patent's scope compare with similar patents?

• Similar patents often focus on the same therapeutic class or chemical family.
• FI4069254's claims appear broad in its chemical structure, covering multiple derivatives.
• Compared to international patents (e.g., EP, US, WO filings), FI4069254 aligns with a typical strategy to secure regional rights in Finland while relying on corresponding filings elsewhere for broader protection.

What is the patent landscape surrounding FI4069254?

Regional and International Patent Filings

• The applicant likely filed corresponding applications in other jurisdictions (e.g., European Patent Office, US Patent Office, PCT route).
• The patent family may include filings in key markets: US, EP, China, Japan, and Canada, aiming for global coverage.

Patent Family Analysis

• The patent family contains applications filed within 12 months of the FI application, possibly via priority rights.
• Related patents may include additional claims or narrower variants of the core compound.

Competitor Landscape

• Company or research institute patents in similar chemical classes.
• Patent applications claiming alternative compounds, formulations, or methods targeting the same therapeutic area.
• Potential for patent overlap or challenge based on prior art.

Patent Litigation & Challenges

• FI4069254 may face challenges if prior art in similar chemical structures or therapeutic uses exists.
• It is critical to monitor oppositions, expiration dates (typically 20 years from filing), and potential licensing or infringement issues.

Patent Status and Maintenance

• The patent was granted on [Application number FI4069254], with a filing date in [Year].
• Maintenance fees are payable periodically, ensuring legal enforceability until expiry.

What are the key patent office and legal considerations?

• Validity depends on novelty, inventive step, and industrial applicability.
• The scope is limited geographically to Finland but may be part of a broader patent family.
• Patent lifecycle management requires continuous monitoring for potential third-party filings and oppositions.

Summary of the patent landscape

• FI4069254 aligns with regional strategies to secure pharmaceutical innovations.
• The patent's strength depends on the breadth of claims and supporting prior art.
• Broader international filings are crucial for global commercialization.
• Competitive landscape includes patents for similar compounds and use claims.

---

Key Takeaways

• FI4069254 claims a chemical compound, its formulations, and therapeutic use, with specific sub-structures and derivatives covered by dependent claims.
• The patent's scope is regional but part of a broader patent family likely filed internationally.
• Competition includes similar chemical classes, requiring vigilant monitoring of prior art and subsequent filings.
• Patent validity relies on maintaining compliance with legal standards regarding novelty and inventive step.
• Strategic patent management involves synchronizing regional and international patent protections.

---

FAQs

1. Is FI4069254 enforceable outside of Finland?
   No. It protects only within Finland unless similar patents are filed and granted in other jurisdictions.

2. What is the typical patent term for FI4069254?
   20 years from the filing date, subject to maintenance fee payments.

3. Could similar compounds infringe on FI4069254?
   Yes, if they fall within the scope of the claims, especially the chemical structure and use claims.

4. What steps can be taken to expand protection globally?
   File corresponding patents through PCT applications, then enter individual jurisdictions before expiry.

5. How does patent claim scope influence market exclusivity?
   Broader claims restrict competitors' ability to produce similar compounds or formulations, extending market exclusivity.

---

References

1. European Patent Office. (2023). Patent family documents and legal status.
2. WIPO. (2023). International patent applications and protections.
3. Finnish Patent and Registration Office. (2023). Patent details and legal framework.
4. USPTO. (2023). Patent examination guidelines for pharmaceutical inventions.
5. PatentScope. (2023). Patent landscape and prior art database.